Surgical Explantation of Transcatheter Aortic Valve Bioprostheses: A Statewide Experience.

ABSTRACT:

Background

Despite the rapid adoption of transcatheter aortic valve replacement (TAVR) since its initial approval in 2011, the frequency and outcomes of surgical explantation of TAVR devices (TAVR-explant) is poorly understood.

Methods

Patients undergoing TAVR-explant between January 2012 and June 2020 at 33 hospitals in Michigan were identified in the Society of Thoracic Surgeons Database and linked to index TAVR data from the Transcatheter Valve Therapy Registry through a statewide quality collaborative. The primary outcome was operative mortality. Indications for TAVR-explant, contraindications to redo TAVR, operative data, and outcomes were collected from Society of Thoracic Surgeons and Transcatheter Valve Therapy databases. Baseline Society of Thoracic Surgeons Predict

SUBMITTER: Brescia AA 

PROVIDER: S-EPMC8058275 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature